{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:15:26Z","timestamp":1787030126945,"version":"build-2736575974"},"reference-count":119,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:00:00Z","timestamp":1630540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI108415"],"award-info":[{"award-number":["R01 AI108415"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>IL-15, a proinflammatory cytokine critical for the generation, maintenance, and homeostasis of T cell responses, is produced naturally in response to HIV\/SIV infection, but has also demonstrated therapeutic potential. IL-15 can boost CD4+ and CD8+ T cell and NK cell proliferation, activation, and function. However, IL-15 treatment may cause aberrant immune activation and accelerated disease progression in certain circumstances. Moreover, the relationship between the timing of IL-15 administration and disease progression remains unclear. The IL-15 superagonist N-803 was developed to expand the therapeutic potential of IL-15 by maximizing its tissue distribution and half-life. N-803 has garnered enthusiasm recently as a way to enhance the innate and cellular immune responses to HIV\/SIV by improving CD8+ T cell recognition and killing of virus-infected cells and directing immune cells to mucosal sites and lymph nodes, the primary sites of virus replication. N-803 has also been evaluated in \u201cshock and kill\u201d strategies due to its potential to reverse latency (shock) and enhance antiviral immunity (kill). This review examines the current literature about the effects of IL-15 and N-803 on innate and cellular immunity, viral burden, and latency reversal in the context of HIV\/SIV, and their therapeutic potential both alone and combined with additional interventions such as antiretroviral therapy (ART) and vaccination.<\/jats:p>","DOI":"10.3390\/v13091750","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T23:55:22Z","timestamp":1630972522000},"page":"1750","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Therapeutic Potential of IL-15 and N-803 in HIV\/SIV Infection"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0315-9645","authenticated-orcid":false,"given":"Olivia","family":"Harwood","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0183-5010","authenticated-orcid":false,"given":"Shelby","family":"O\u2019Connor","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.3389\/fimmu.2019.01435","article-title":"The HIV Reservoir in Monocytes and Macrophages","volume":"10","author":"Wong","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2052-8426-2-20","article-title":"Making sense of how HIV kills infected CD4 T cells: Implications for HIV cure","volume":"2","author":"Cummins","year":"2014","journal-title":"Mol. Cell. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/35073658","article-title":"Cellular immune responses to HIV","volume":"410","author":"McMichael","year":"2001","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.4049\/jimmunol.178.11.6975","article-title":"CTL Fail to Accumulate at Sites of HIV-1 Replication in Lymphoid Tissue","volume":"178","author":"Connick","year":"2007","journal-title":"J. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)69157-5","article-title":"HIV\/AIDS epidemiology, pathogenesis, prevention, and treatment","volume":"368","author":"Simon","year":"2006","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"13778","DOI":"10.1073\/pnas.250472097","article-title":"Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients","volume":"97","author":"Lempicki","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1084\/jem.194.12.1731","article-title":"Identification of Dynamically Distinct Subpopulations of T Lymphocytes That Are Differentially Affected by HIV","volume":"194","author":"Kovacs","year":"2001","journal-title":"J. Exp. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.4049\/jimmunol.1002000","article-title":"CD4 and CD8 T Cell Immune Activation during Chronic HIV Infection: Roles of Homeostasis, HIV, Type I IFN, and IL-7","volume":"186","author":"Catalfamo","year":"2011","journal-title":"J. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.4049\/jimmunol.181.2.1573","article-title":"Restoration of the CD4 T Cell Compartment after Long-Term Highly Active Antiretroviral Therapy without Phenotypical Signs of Accelerated Immunological Aging","volume":"181","author":"Vrisekoop","year":"2008","journal-title":"J. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nm0597-533","article-title":"HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies","volume":"3","author":"Connors","year":"1997","journal-title":"Nat. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"a007161","DOI":"10.1101\/cshperspect.a007161","article-title":"HIV-1 Antiretroviral Drug Therapy","volume":"2","author":"Arts","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1172\/JCI126714","article-title":"HIV-1 in lymph nodes is maintained by cellular proliferation during antiretroviral therapy","volume":"129","author":"McManus","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3389\/fimmu.2019.00291","article-title":"Harnessing CD8+ T Cells under HIV Antiretroviral Therapy","volume":"10","author":"Warren","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/s41591-018-0026-6","article-title":"Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection","volume":"24","author":"Colby","year":"2018","journal-title":"Nat. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/COH.0000000000000528","article-title":"Role of cytokine agonists and immune checkpoint inhibitors toward HIV remission","volume":"14","author":"Hoang","year":"2019","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4172\/2332-0877.1000102","article-title":"Immunotherapy in HIV Infection","volume":"1","author":"Poonia","year":"2013","journal-title":"J. Infect. Dis. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Hokello, J., Sharma, A.L., Dimri, M., and Tyagi, M. (2019). Insights into the HIV Latency and the Role of Cytokines. Pathogens, 8.","DOI":"10.3390\/pathogens8030137"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.it.2004.11.002","article-title":"IL-7 and IL-15: Therapeutic cytokines for immunodeficiency","volume":"26","author":"Alpdogan","year":"2005","journal-title":"Trends Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1749-6632.2002.tb05940.x","article-title":"IL-15 Is a Growth Factor and an Activator of CD8 Memory T Cells","volume":"975","author":"Weng","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cyto.2012.05.020","article-title":"Functions of IL-15 in anti-viral immunity: Multiplicity and variety","volume":"59","author":"Verbist","year":"2012","journal-title":"Cytokine"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1158\/1078-0432.CCR-12-3603","article-title":"Molecular Pathways: Interleukin-15 Signaling in Health and in Cancer","volume":"20","author":"Mishra","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.4049\/jimmunol.167.3.1179","article-title":"IL-15 Is Expressed by Dendritic Cells in Response to Type I IFN, Double-Stranded RNA, or Lipopolysaccharide and Promotes Dendritic Cell Activation","volume":"167","author":"Mattei","year":"2001","journal-title":"J. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/j.molimm.2011.07.008","article-title":"IFN-\u03b1 primes T- and NK-cells for IL-15-mediated signaling and cytotoxicity","volume":"48","author":"Hansen","year":"2011","journal-title":"Mol. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"434","DOI":"10.21037\/atm.2017.08.38","article-title":"Very early antiretroviral therapy permits CD8 T cells to keep HIV reservoirs at bay","volume":"5","author":"Routy","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1172\/JCI91916","article-title":"The interferon paradox: Can inhibiting an antiviral mechanism advance an HIV cure?","volume":"127","author":"Deeks","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.12688\/f1000research.12202.1","article-title":"The \u03b3c family of cytokines: Fine-tuning signals from IL-2 and IL-21 in the regulation of the immune response","volume":"6","author":"Spolski","year":"2017","journal-title":"F1000Research"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/1074-7613(95)90141-8","article-title":"The role of shared receptor motifs and common stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15","volume":"2","author":"Lin","year":"1995","journal-title":"Immunity"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/ni.2472","article-title":"IL-2 and IL-15 signaling complexes: Different but the same","volume":"13","author":"Ikemizu","year":"2012","journal-title":"Nat. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1158\/2326-6066.CIR-15-0009","article-title":"The Shared and Contrasting Roles of IL2 and IL15 in the Life and Death of Normal and Neoplastic Lymphocytes: Implications for Cancer Therapy","volume":"3","author":"Waldmann","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1182\/blood-2008-12-189266","article-title":"Safety and immunologic effects of IL-15 administration in nonhuman primates","volume":"114","author":"Berger","year":"2009","journal-title":"Blood"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.4049\/jimmunol.177.9.6072","article-title":"Combined IL-15\/IL-15R\u03b1 Immunotherapy Maximizes IL-15 Activity In Vivo","volume":"177","author":"Stoklasek","year":"2006","journal-title":"J. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1182\/blood.V97.1.14","article-title":"Interleukin 15: Biology and relevance to human disease","volume":"97","author":"Fehniger","year":"2001","journal-title":"Blood"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1126\/science.7973659","article-title":"Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits","volume":"266","author":"Miyazaki","year":"1994","journal-title":"Science"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"8705","DOI":"10.1073\/pnas.92.19.8705","article-title":"Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15","volume":"92","author":"Johnston","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_35","first-page":"105","article-title":"Contrasting Roles of IL-2 and IL-15 in the Life and Death of Lymphocytes Implications for Immunotherapy","volume":"14","author":"Waldmann","year":"2001","journal-title":"Immunity"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.2337\/db15-0188","article-title":"Therapeutic Window of Interleukin-2 for Autoimmune Diseases","volume":"64","author":"Tang","year":"2015","journal-title":"Diabetes"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1182\/blood-2005-06-2399","article-title":"IL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patients","volume":"107","author":"Ahmadzadeh","year":"2006","journal-title":"Blood"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6249","DOI":"10.1021\/acs.jmedchem.7b00485","article-title":"Discovery of a Small-Molecule Inhibitor of Interleukin 15: Pharmacophore-Based Virtual Screening and Hit Optimization","volume":"60","author":"Maillasson","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pep.2009.05.004","article-title":"coli expression and purification of human and cynomolgus IL-15","volume":"68","author":"Ward","year":"2009","journal-title":"Protein Expr. Purif."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pep.2018.03.010","article-title":"A novel strategy to produce high level and high purity of bioactive IL15 fusion proteins from mammalian cells","volume":"148","author":"Huang","year":"2018","journal-title":"Protein Expr. Purif."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1210\/en.2015-1746","article-title":"Free IL-15 Is More Abundant Than IL-15 Complexed With Soluble IL-15 Receptor-\u03b1 in Murine Serum: Implications for the Mechanism of IL-15 Secretion","volume":"157","author":"Anderson","year":"2016","journal-title":"Endocrinology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1182\/blood-2010-10-311456","article-title":"Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques","volume":"117","author":"Waldmann","year":"2011","journal-title":"Blood"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1182\/blood-2010-03-275438","article-title":"Transient and persistent effects of IL-15 on lymphocyte homeostasis in nonhuman primates","volume":"116","author":"Lugli","year":"2010","journal-title":"Blood"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1016\/j.vaccine.2003.07.022","article-title":"IL-15 is superior to IL-2 in the generation of long-lived antigen specific memory CD4 and CD8 T cells in rhesus macaques","volume":"22","author":"Villinger","year":"2004","journal-title":"Vaccine"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.1182\/blood-2011-09-377804","article-title":"IL-15 administered by continuous infusion to rhesus macaques induces massive expansion of CD8+ T effector memory population in peripheral blood","volume":"118","author":"Sneller","year":"2011","journal-title":"Blood"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1128\/jvi.68.9.6103-6110.1994","article-title":"Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection","volume":"68","author":"Borrow","year":"1994","journal-title":"J. Virol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1128\/jvi.68.7.4650-4655.1994","article-title":"Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome","volume":"68","author":"Koup","year":"1994","journal-title":"J. Virol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/487439a","article-title":"Shock and kill","volume":"487","author":"Deeks","year":"2012","journal-title":"Nature"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1182\/blood-2002-07-1957","article-title":"IL-15 enhances survival and function of HIV-specific CD8+ T cells","volume":"101","author":"Mueller","year":"2003","journal-title":"Blood"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/intimm\/dxg013","article-title":"IL-15 enhances the function and inhibits CD95\/Fas-induced apoptosis of human CD4+ and CD8+ effector-memory T cells","volume":"15","author":"Mueller","year":"2003","journal-title":"Int. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1128\/JVI.79.8.4877-4885.2005","article-title":"Interleukin-15 Increases Effector Memory CD8 + T Cells and NK Cells in Simian Immunodeficiency Virus-Infected Macaques","volume":"79","author":"Mueller","year":"2005","journal-title":"J. Virol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1182\/blood-2011-05-351155","article-title":"IL-15 delays suppression and fails to promote immune reconstitution in virally suppressed chronically SIV-infected macaques","volume":"118","author":"Lugli","year":"2011","journal-title":"Blood"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cytogfr.2017.08.002","article-title":"Immunobiology of the IL-15\/IL-15R\u03b1 complex as an antitumor and antiviral agent","volume":"38","author":"Guo","year":"2017","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1172\/JCI27564","article-title":"IL-15 induces CD4+ effector memory T cell production and tissue emigration in nonhuman primates","volume":"116","author":"Picker","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.4049\/jimmunol.178.6.3492","article-title":"Interleukin-15 but Not Interleukin-7 Abrogates Vaccine-Induced Decrease in Virus Level in Simian Immunodeficiency Virusmac251-Infected Macaques","volume":"178","author":"Hryniewicz","year":"2007","journal-title":"J. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1084\/jem.20041049","article-title":"Insufficient Production and Tissue Delivery of CD4+Memory T Cells in Rapidly Progressive Simian Immunodeficiency Virus Infection","volume":"200","author":"Picker","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cytogfr.2016.06.001","article-title":"Interleukin 15: A key cytokine for immunotherapy","volume":"31","author":"Patidar","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.4049\/jimmunol.1600065","article-title":"Effect of Anti\u2013IL-15 Administration on T Cell and NK Cell Homeostasis in Rhesus Macaques","volume":"197","author":"DeGottardi","year":"2016","journal-title":"J. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Watson, D.C., Moysi, E., Valentin, A., Bergamaschi, C., Devasundaram, S., Fortis, S.P., Bear, J., Chertova, E., Bess, J., and Sowder, R. (2018). Correction: Treatment with native heterodimeric IL-15 increases cytotoxic lymphocytes and reduces SHIV RNA in lymph nodes. PLOS Pathog., 14.","DOI":"10.1371\/journal.ppat.1007345"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.4049\/jimmunol.158.12.5978","article-title":"IL-15 enhances immune functions during HIV infection","volume":"158","author":"Chehimi","year":"1997","journal-title":"J. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e00235-18","DOI":"10.1128\/JVI.00235-18","article-title":"Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal Ex Vivo","volume":"92","author":"Garrido","year":"2018","journal-title":"J. Virol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1086\/377454","article-title":"Levels of Interleukin?15 in Plasma May Predict a Favorable Outcome of Structured Treatment Interruption in Patients with Chronic Human Immunodeficiency Virus Infection","volume":"188","author":"Amicosante","year":"2003","journal-title":"J. Infect. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"7969","DOI":"10.4049\/jimmunol.180.12.7969","article-title":"Therapeutic Vaccination with Simian Immunodeficiency Virus (SIV)-DNA+IL-12 or IL-15 Induces Distinct CD8 Memory Subsets in SIV-Infected Macaques","volume":"180","author":"Halwani","year":"2008","journal-title":"J. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.vaccine.2009.10.099","article-title":"Repeated DNA therapeutic vaccination of chronically SIV-infected macaques provides additional virological benefit","volume":"28","author":"Valentin","year":"2010","journal-title":"Vaccine"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.vaccine.2014.12.046","article-title":"Differential effects of IL-15 on the generation, maintenance and cytotoxic potential of adaptive cellular responses induced by DNA vaccination","volume":"33","author":"Li","year":"2015","journal-title":"Vaccine"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1073\/pnas.0630592100","article-title":"Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity","volume":"100","author":"Oh","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"18648","DOI":"10.1073\/pnas.0709198104","article-title":"Protection against simian\/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid","volume":"104","author":"Boyer","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/infdis\/jit236","article-title":"Safety and Comparative Immunogenicity of an HIV-1 DNA Vaccine in Combination with Plasmid Interleukin 12 and Impact of Intramuscular Electroporation for Delivery","volume":"208","author":"Kalams","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Kalams, S.A., Parker, S., Jin, X., Elizaga, M., Metch, B., Wang, M., Hural, J., Lubeck, M., Eldridge, J., and Cardinali, M. (2012). Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine with or without IL-12 and\/or IL-15 Plasmid Cytokine Adjuvant in Healthy, HIV-1 Uninfected Adults. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0029231"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1128\/JVI.01844-08","article-title":"Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections","volume":"83","author":"Stacey","year":"2009","journal-title":"J. Virol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.4049\/jimmunol.182.3.1439","article-title":"Increased IL-15 Production Is Associated with Higher Susceptibility of Memory CD4 T Cells to Simian Immunodeficiency Virus during Acute Infection","volume":"182","author":"Eberly","year":"2009","journal-title":"J. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Swaminathan, S., Qiu, J., Rupert, A.W., Hu, Z., Higgins, J., Dewar, R.L., Stevens, R., Rehm, C.A., Metcalf, J.A., and Sherman, B.T. (2016). Interleukin-15 (IL-15) Strongly Correlates with Increasing HIV-1 Viremia and Markers of Inflammation. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0167091"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1172\/JCI85996","article-title":"IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection","volume":"126","author":"Younes","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.clim.2007.05.005","article-title":"Immunophenotypic patterns of CD8+ T cell subsets expressing CD8\u03b1\u03b1 and IL-7R\u03b1 in viremic, aviremic and slow progressor HIV-1-infected subjects","volume":"124","author":"Boulassel","year":"2007","journal-title":"Clin. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1034\/j.1600-0684.2001.d01-57.x","article-title":"Chronic immune stimulation accelerates SIV-induced disease progression","volume":"30","author":"Villinger","year":"2001","journal-title":"J. Med. Primatol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"8413","DOI":"10.1128\/JVI.74.18.8413-8424.2000","article-title":"Differential Dynamics of CD4 + and CD8 + T-Lymphocyte Proliferation and Activation in Acute Simian Immunodeficiency Virus Infection","volume":"74","author":"Kaur","year":"2000","journal-title":"J. Virol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"6798","DOI":"10.4049\/jimmunol.180.10.6798","article-title":"Early Resolution of Acute Immune Activation and Induction of PD-1 in SIV-Infected Sooty Mangabeys Distinguishes Nonpathogenic from Pathogenic Infection in Rhesus Macaques","volume":"180","author":"Estes","year":"2008","journal-title":"J. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1023\/A:1023246800353","article-title":"Induction of HIV-1 replication by type 1-like cytokines, interleukin (IL)-12 and IL-15: Effect on viral transcriptional activation, cellular proliferation, and endogenous cytokine production","volume":"18","author":"Roebuck","year":"1998","journal-title":"J. Clin. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1172\/JCI118831","article-title":"Activation of Antigen-induced Lymphocyte Proliferation by Interleukin-15 without the Mitogenic Effect of Interleukin-2 that may In-duce Human Immunodeficiency Virus\u20131 Expression","volume":"98","author":"Patki","year":"1996","journal-title":"J. Clin. Investig."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4049\/jimmunol.180.1.350","article-title":"IL-15 Treatment during Acute Simian Immunodeficiency Virus (SIV) Infection Increases Viral Set Point and Accelerates Disease Progression despite the Induction of Stronger SIV-Specific CD8+T Cell Responses","volume":"180","author":"Mueller","year":"2007","journal-title":"J. Immunol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1084\/jem.20090356","article-title":"Profound CD4+\/CCR5+ T cell expansion is induced by CD8+ lymphocyte depletion but does not account for accelerated SIV pathogenesis","volume":"206","author":"Okoye","year":"2009","journal-title":"J. Exp. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"E9659","DOI":"10.1073\/pnas.1806695115","article-title":"IL-15 regulates susceptibility of CD4+ T cells to HIV infection","volume":"115","author":"Manganaro","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.4049\/jimmunol.1900792","article-title":"Role of IL-15 Signaling in the Pathogenesis of Simian Immunodeficiency Virus Infection in Rhesus Macaques","volume":"203","author":"Okoye","year":"2019","journal-title":"J. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fimmu.2018.00020","article-title":"The B-Cell Follicle in HIV Infection: Barrier to a Cure","volume":"9","author":"Bronnimann","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/nm.4421","article-title":"Natural killer cells migrate into and control simian immunodeficiency virus replication in lymph node follicles in African green monkeys","volume":"23","author":"Huot","year":"2017","journal-title":"Nat. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3389\/fimmu.2018.00780","article-title":"Lymph Node Cellular and Viral Dynamics in Natural Hosts and Impact for HIV Cure Strategies","volume":"9","author":"Huot","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cyto.2018.01.011","article-title":"Optimized administration of hetIL-15 expands lymphocytes and minimizes toxicity in rhesus macaques","volume":"108","author":"Bergamaschi","year":"2018","journal-title":"Cytokine"},{"key":"ref_88","first-page":"1","article-title":"Characterization of Interleukin-15-Transpresenting Dendritic Cells for Clinical Use","volume":"2017","author":"Smits","year":"2017","journal-title":"J. Immunol. Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"9166","DOI":"10.1073\/pnas.0600240103","article-title":"Converting IL-15 to a superagonist by binding to soluble IL-15R","volume":"103","author":"Rubinstein","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Jones, R.B., Mueller, S., O\u2019Connor, R., Rimpel, K., Sloan, D.D., Karel, D., Wong, H.C., Jeng, E.K., Thomas, A., and Whitney, J.B. (2016). A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005545"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Webb, G.M., Molden, J., Busman-Sahay, K., Abdulhaqq, S., Wu, H.L., Weber, W.C., Bateman, K.B., Reed, J.S., Northrup, M., and Maier, N. (2020). The human IL-15 superagonist N-803 promotes migration of virus-specific CD8+ T and NK cells to B cell follicles but does not reverse latency in ART-suppressed, SHIV-infected macaques. PLOS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008339"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41586-020-1946-0","article-title":"Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells","volume":"578","author":"McBrien","year":"2020","journal-title":"Nature"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"McBrien, J.B., Wong, A.K.H., White, E., Carnathan, D.G., Lee, J.H., Safrit, J.T., Vanderford, T.H., Paiardini, M., Chahroudi, A., and Silvestri, G. (2020). Combination of CD8\u03b2 Depletion and Interleukin-15 Superagonist N-803 Induces Virus Reactivation in Simian-Human Immunodeficiency Virus-Infected, Long-Term ART-Treated Rhesus Macaques. J. Virol., 94.","DOI":"10.1128\/JVI.00755-20"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.4049\/jimmunol.0901244","article-title":"Novel Human Interleukin-15 Agonists","volume":"183","author":"Zhu","year":"2009","journal-title":"J. Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cyto.2011.09.028","article-title":"IL-15:IL-15 receptor alpha superagonist complex: High-level co-expression in recombinant mammalian cells, purification and characterization","volume":"56","author":"Han","year":"2011","journal-title":"Cytokine"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1158\/1078-0432.CCR-18-0945","article-title":"Phasze I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid Tumors","volume":"24","author":"Margolin","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1158\/0008-5472.CAN-12-2357","article-title":"Efficacy and Mechanism-of-Action of a Novel Superagonist Interleukin-15: Interleukin-15 Receptor \u03b1Su\/Fc Fusion Complex in Syngeneic Murine Models of Multiple Myeloma","volume":"73","author":"Xu","year":"2013","journal-title":"Cancer Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1158\/2326-6066.CIR-15-0093-T","article-title":"Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models","volume":"4","author":"Rhode","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"7675","DOI":"10.1038\/s41598-018-25987-4","article-title":"Discovery of a novel IL-15 based protein with improved developability and efficacy for cancer immunotherapy","volume":"8","author":"Hu","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e01748-17","DOI":"10.1128\/JVI.01748-17","article-title":"ALT-803 Transiently Reduces Simian Immunodeficiency Virus Replication in the Absence of Antiretroviral Treatment","volume":"92","author":"Balgeman","year":"2018","journal-title":"J. Virol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1182\/bloodadvances.2017012971","article-title":"The human IL-15 superagonist ALT-803 directs SIV-specific CD8+ T cells into B-cell follicles","volume":"2","author":"Webb","year":"2018","journal-title":"Blood Adv."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1182\/blood-2017-12-823757","article-title":"First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation","volume":"131","author":"Romee","year":"2018","journal-title":"Blood"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cyto.2017.12.003","article-title":"Evaluation of the biological activities of the IL-15 superagonist complex, ALT-803, following intravenous versus subcutaneous administration in murine models","volume":"107","author":"Liu","year":"2018","journal-title":"Cytokine"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S1470-2045(18)30148-7","article-title":"ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: A non-randomised, open-label, phase 1b trial","volume":"19","author":"Wrangle","year":"2018","journal-title":"Lancet Oncol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1128\/JVI.00563-15","article-title":"In VivoActivation of Human NK Cells by Treatment with an Interleukin-15 Superagonist Potently Inhibits AcuteIn VivoHIV-1 Infection in Humanized Mice","volume":"89","author":"Seay","year":"2015","journal-title":"J. Virol."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Banga, R., Rebecchini, C., Procopio, F.A., Noto, A., Munoz, O., Ioannidou, K., Fenwick, C., Ohmiti, K., Cavassini, M., and Corpataux, J.-M. (2019). Lymph node migratory dendritic cells modulate HIV-1 transcription through PD-1 engagement. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1007918"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nm.3781","article-title":"B cell follicle sanctuary permits persistent productive SIV infection in elite controllers","volume":"21","author":"Fukazawa","year":"2015","journal-title":"Nat. Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.4049\/jimmunol.1401161","article-title":"Compartmentalization of Simian Immunodeficiency Virus Replication within Secondary Lymphoid Tissues of Rhesus Macaques Is Linked to Disease Stage and Inversely Related to Localization of Virus-Specific CTL","volume":"193","author":"Connick","year":"2014","journal-title":"J. Immunol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ni.3543","article-title":"CXCR5+ follicular cytotoxic T cells control viral infection in B cell follicles","volume":"17","author":"Leong","year":"2016","journal-title":"Nat. Immunol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3389\/fimmu.2018.01452","article-title":"Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure","volume":"9","author":"Clutton","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ebiom.2019.06.020","article-title":"Deep latency: A new insight into a functional HIV cure","volume":"45","author":"Elsheikh","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3389\/fimmu.2015.00506","article-title":"Challenges and Opportunities for T-Cell-Mediated Strategies to Eliminate HIV Reservoirs","volume":"6","author":"Brockman","year":"2015","journal-title":"Front. Immunol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nature01076","article-title":"Direct observation of ligand recognition by T cells","volume":"419","author":"Irvine","year":"2002","journal-title":"Nature"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Elliott, J.H., Wightman, F., Solomon, A., Ghneim, K., Ahlers, J., Cameron, M.J., Smith, M.Z., Spelman, T., McMahon, J., and Velayudham, P. (2014). Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004473"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S2352-3018(15)00226-X","article-title":"Short-term Disulfiram to Reverse Latent HIV Infection: A Phase 2 Dose Escalation Study","volume":"2","author":"Elliott","year":"2015","journal-title":"Lancet HIV"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/cid\/cit813","article-title":"A Pilot Study Assessing the Safety and Latency-Reversing Activity of Disulfiram in HIV-1-Infected Adults on Antiretroviral Therapy","volume":"58","author":"Spivak","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/infdis\/jiu155","article-title":"HIV-1 Expression Within Resting CD4+ T Cells After Multiple Doses of Vorinostat","volume":"210","author":"Archin","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"S\u00f8gaard, O., Graversen, M.E., Leth, S., Olesen, R., Brinkmann, C.R., Nissen, S.K., Kjaer, A., Schleimann, M., Denton, P., and Hey-Cunningham, W.J. (2015). The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1005142"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.immuni.2016.08.018","article-title":"CD8 + Lymphocytes Are Required for Maintaining Viral Suppression in SIV-Infected Macaques Treated with Short-Term Antiretroviral Therapy","volume":"45","author":"Cartwright","year":"2016","journal-title":"Immunity"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/9\/1750\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:54:40Z","timestamp":1760165680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/9\/1750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,2]]},"references-count":119,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["v13091750"],"URL":"https:\/\/doi.org\/10.3390\/v13091750","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,2]]}}}